The effect of phenoxybenzamine, phentolamine and 6-hydroxydopamine on skin flap survival in rats.
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001166:Arteriovenous Shunt, Surgical; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D009336:Necrosis; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000494:pharmacology*; D010646:Phentolamine / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000517:prevention & control; D016038:Skin Transplantation; D014182:Transplantation, Autologous
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D006892:Hydroxydopamines; D010643:Phenoxybenzamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine